Halime Şahan

Halime Şahan

Auto-generated profile, based on publicly available information

Halime Şahan

Department of Neurology, Faculty of Medicine, Düzce University, Düzce, Türkiye

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2024 in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Verified
Journal Article
Open access
PDF file
HŞHalime Şahan
Halime Şahan
AYAhmet Yabalak
Ahmet Yabalak
Background: Mild encephalopathy wıth reversible splenial lesions (MERS) are a clinical–radiological diagnosis that can be diagnosed with radiological imaging and can be accompanied by impaired consciousness, aphasia, headache, and paralysis. MERS can be divided into two different types based on radiological findings; Involvement of the splenium is seen in type 1, and involvement of the splenium and deep white matter is seen in type 2. MERS Type 2 is very rare in adults. Here, we describe a patient diagnosed with MERS Type 2 and our therapeutic intervention. Case presentation: A 22-year-old woman presented with slurred speech, weakness in the extremities and headache that started 14 h ago. The patient had sore throat and fever of 37.6 °C for 2 days, and medical history or family history were unremarkable. Neurological examination revealed that she was conscious, cooperative, with no signs of meningeal irritation. Speech comprehension, naming, and repetition were preserved, motor examination revealed 5/5 left upper extremity strength, 4/5 right upper extremity strength, and 2/5 bilateral lower extremity strength. Diffusion-weighted magnetic resonance imaging (MRI-DWI) revealed bilateral deep white matter and splenium symmetrical diffusion restriction. Blood tests showed high C-reactive protein (CRP) and no leukocytosis. No cells were detected in the cerebrospinal fluid (CSF), protein was 151 mg/dl, glucose was within normal limits. The patient, who developed quadriparesis during follow-up, was started on pulse dose steroids. Neurological examination improved to patient’s baseline at the 12th hour of treatment. In the 72nd hour control MRI-DWI, it was seen that the lesions had regressed. Culture/Polymerase chain reaction (PCR) for bacterial/viral infection agents came back negative. After steroids were given for 5 days, patient was discharged at her baseline. Conclusions: MERS is a rare diagnosis in adults and can be radiologically confused with acute toxic leukoencephalopathy. It can be distinguished clinically by the absence of prior infection, fever, and toxic agent exposure. Although there is no consensus in the literature regarding the treatment, the clinical picture improved rapidly after steroid in our case. Despite being rare, it should be considered in the differential diagnosis of patients with deep white matter lesions in adults.

1 September 2023 in European Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
MEMehmet Tahir Eski
Mehmet Tahir Eski
AYAHMET Yabalak
AHMET Yabalak
HŞHalime Şahan
Halime Şahan
AAAlper Aziz Hüdai Ayaslı
Alper Aziz Hüdai Ayaslı
TSTaha Sezer
Taha Sezer
Introduction and aim. Purpose of the study is to determine whether it is required to use different standards when evaluating visual evoked potential (VEP) measurements of healthy individuals with different blood groups. Material and methods. The study consisted of healthy individuals with different blood groups who have applied to the ophthalmology and neurology outpatient clinic of Düzce University Medical Faculty from January to December 2022. The patients went through detailed ophthalmologic examination and VEP test and only the ones with normal results were included to the study. Results. The study consisted of 119 individuals, with a blood group distribution of 30 A, 29 B, 30 AB and 30 O. VEP latency and amplitude changes were compared and no significant difference was observed within 4 groups in terms of P100 and N70 latency and amplitudes. There was N70 latency prolongation in Rh- group and this difference was found to be statistically significant (p=0.009). Rh+ group was found to be high in terms of P100 amplitudes and this was considered statistically significant (both p=0.023). Conclusion. There was no statistically significant difference in the VEP parameters of the individuals with the ABO blood groups hence same VEP normal values can be used for ABO blood groups.

31 July 2026 in Northwestern Medical Journal
Verified
Journal Article
Open access
PDF file
OZOrkun Zorsu
Orkun Zorsu
AYAHMET Yabalak
AHMET Yabalak
HŞHalime Şahan
Halime Şahan
Background: Restless Legs Syndrome (RLS) is a neurological disorder primarily linked to dopaminergic dysfunction. Since vitamin D plays a role in modulating the dopaminergic system, this study aimed to evaluate the impact of vitamin D supplementation on symptom severity, sleep quality, depression, and fatigue in patients with idiopathic RLS and vitamin D deficiency. Methods: This study retrospectively evaluated patients with idiopathic RLS and vitamin D deficiency who presented to our clinic between April 2022 and March 2023. Participants received weekly oral supplementation of 50,000 IU vitamin D and were assessed at baseline and at 3 months using the International Restless Legs Syndrome Study Group (IRLS) Symptom Scale, Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). Results: Twenty-five patients (10 females and 15 males) meeting the eligibility criteria were enrolled. Following vitamin D replacement, mean serum 25-hydroxyvitamin D [25(OH)D] levels increased significantly from 16.91 ± 8.09 ng/mL to 38.08 ± 9.58 ng/mL (p< 0.001). A statistically significant reduction was observed in IRLS symptom severity scores (15.36 ± 6.75 vs. 14.28 ± 6.22, p = 0.019). However, no statistically significant changes were found in FSS, PSQI, and BDI scores (p = 0.058, 0.242, and 0.846, respectively). Conclusion: Vitamin D supplementation appears to reduce symptom severity in patients with idiopathic RLS and vitamin D deficiency; however, its impact on sleep quality, depression, and fatigue warrants further investigation. Large-scale, randomized controlled trials are necessary to confirm these preliminary findings and define the role of vitamin D in RLS management.

1 September 2024 in Neurology Asia
Verified
Journal Article
Closed access
AYAHMET Yabalak
AHMET Yabalak
MOMuhammed Nur Ogun
Muhammed Nur Ogun
ADAyse Onalan Isimler Düzelitmeli
Ayse Onalan Isimler Düzelitmeli
EKEzgi Ayse Cakir Karahan
Ezgi Ayse Cakir Karahan
HSHalime Sahan
Halime Sahan
HTHilmiye Tokmak
Hilmiye Tokmak
Background: Despite current developments in mechanical thrombectomy (MT), successful recanalization cannot be achieved in all patients. One of the factors related to this is the characteristics of the thrombus. In this study, we aimed to evaluate the effects of thrombus length and permeability on procedural success and clinical outcome. Methods: Patients with intracranial ICA, middle cerebral artery M1, or M2 occlusions, who underwent MT between November 2019 and January 2022 were included in the study. Thrombus length, density and permeability were calculated and the relationship between recanalization success and modified Rankin Scores (mRS) at the 3rd month was evaluated. Good clinical outcome was defined as an mRS score of 2 or less. Results: Forty-six of the 79 patients included in the study had a good clinical outcome. Although thrombus length was shorter and permeability was higher in patients with good clinical outcome, statistical significance was not achieved. There was a positive correlation between thrombus density, thrombus length and the number of passes, and a negative correlation between permeability. There was no significant difference in thrombus length, density and permeability between patients with and without successful recanalisation. Thrombus length was found to be a predictor of clinical outcome at 3 months in univariate analysis, whereas only age was found to be an independent predictor in multivariate analysis. Conclusions: In conclusion, despite certain findings not achieving statistical significance, the observed trends offer valuable insights for future research. A comprehensive understanding of thrombus nature could guide personalized stroke treatment strategies in the future.

24 April 2026 in Northwestern Medical Journal
Verified
Journal Article
Open access
HTHilmiye Tokmak
Hilmiye Tokmak
AYAHMET Yabalak
AHMET Yabalak
AÖAyşegül Özyılmaz
Ayşegül Özyılmaz
HŞHalime Şahan
Halime Şahan
MAMerve Alpay
Merve Alpay
Objective: Early diagnosis of acute ischemic stroke patients with large vessel occlusion and the transfer of patients who require endovascular treatment to stroke centers specific for treatment are of critical importance for patients. Pentraxin-3 (PTX-3) is a biomarker indicating vascular inflammation, and its role in stroke and its relationship with clinical features are being investigated. In this study, the value of PTX-3 levels in the diagnosis of LVO and its relationship with clinical features were evaluated. Methods: Retrospective and prospective patients diagnosed with acute ischemic stroke were included in this study. Patients were divided into two groups as those with and without LVO according to imaging findings. Serum PTX-3 levels were measured and compared between the groups. Stroke severity was evaluated at admission using the National Institutes of Health Stroke Scale (NIHSS), and clinical outcome was evaluated at the 90th day using the modified Rankin Scale (mRS). Correlation, ROC analysis, and logistic regression methods were used in statistical analyses. Results: Data of 81 patients were analyzed in the study. Although PTX-3 levels were found to be higher in patients with LVO, this difference was not statistically significant. The discriminative power of PTX-3 for LVO was found to be limited (AUC = 0.58). A positive correlation was found between PTX-3 levels and admission NIHSS. Although an association between PTX-3 and poor clinical outcome was observed in univariate analyses, it was shown that it was not an independent marker in multivariable analyses. The addition of PTX-3 to clinical models did not increase predictive power. Conclusion: In patients with acute ischemic stroke with LVO, PTX-3 was found not to be a sufficient biomarker in confirming the diagnosis. Although PTX-3 was found to be associated with stroke severity, it cannot predict clinical outcome on its own. Based on the current findings, PTX-3 does not appear to have a clear contribution to the clinical decision-making process.

24 April 2026 in Northwestern Medical Journal
Verified
Journal Article
Open access
PDF file
HTHilmiye Tokmak
Hilmiye Tokmak
AYAHMET Yabalak
AHMET Yabalak
AÖAyşegül Özyılmaz
Ayşegül Özyılmaz
HŞHalime Şahan
Halime Şahan
MAMerve Alpay
Merve Alpay
Objective: Early diagnosis of acute ischemic stroke patients with large vessel occlusion (LVO) and the transfer of patients who require endovascular treatment to specialized stroke centers are critical for patients. Pentraxin-3 (PTX-3) is a biomarker of vascular inflammation, and its role in stroke, including its relationship with clinical features, is being investigated. In this study, we evaluated the value of PTX-3 levels in the diagnosis of LVO and their relationship with clinical features. Methods: This study included retrospectively and prospectively enrolled patients diagnosed with acute ischemic stroke. Patients were divided into two groups according to imaging findings: those with and those without LVO. Serum PTX-3 levels were measured and compared between the groups. Stroke severity was evaluated at admission using the National Institutes of Health Stroke Scale (NIHSS), and clinical outcome was evaluated at the 90th day using the modified Rankin Scale (mRS). Correlation, ROC analysis, and logistic regression methods were used in statistical analyses. Results: Data from 81 patients were analyzed. Although PTX-3 levels were higher in patients with LVO, the difference was not statistically significant. The discriminative power of PTX-3 for LVO was limited (AUC = 0.58). A positive correlation was found between PTX-3 levels and admission NIHSS. Although an association between PTX-3 and poor clinical outcome was observed in univariate analyses, PTX-3 was not an independent marker in multivariable analyses. The addition of PTX-3 to clinical models did not increase predictive power. Conclusion: In patients with acute ischemic stroke with LVO, PTX-3 was not a sufficient biomarker for confirming the diagnosis. Although PTX-3 was associated with stroke severity, it could not predict clinical outcome independently. Based on the current findings, PTX-3 does not appear to have a clear contribution to the clinical decision-making process.